From: Impact evaluation and association with EuroQol 5D health-related utility values in Ménière’s disease
Motility | Self-care | Usual activities | Pain | Mood | |
---|---|---|---|---|---|
Vertigo severity | n.s. | 0.19* | n.s. | n.s. | n.s. |
Nausea AND vomiting | n.s. | 0.15* | n.s. | n.s. | n.s. |
Tumarkin attack | 0.184* | n.s. | 0.252** | 0.216** | n.s. |
Balance problems | 0.496** | n.s. | 0.451** | 0.258** | n.s. |
Unsteadiness | 0.506** | 0.198** | 0.514** | 0.321** | n.s. |
Moving ability | 0.559** | 0.357** | 0.446** | 0.386** | n.s. |
Chair rise | 0.442** | 0.271** | 0.381** | 0.350** | 0.176* |
Impact of vertigo | 0.249** | 0.158* | 0.272** | 0.236** | n.s. |
Tinnitus impact | 0.156* | n.s. | n.s. | 0.125 | n.s. |
Balance impact | 0.569** | 0.327** | 0.433** | 0.371** | 0.225** |
Hearing impact | n.s. | n.s. | n.s. | n.s. | n.s. |
Pressure impact | 0.226** | 0.229** | 0.214** | 0.198** | |
Anxiety/nervousness | 0.181* | n.s. | 0.219** | 0.214** | 0.349** |
Energetics/fatigue | 0.286** | 0.159* | 0.356** | 0.344** | 0.316** |
Sense of coherence | −0.185* | −0.182* | −0.264** | −0.272** | −0.417** |